Aberrant pre-mRNA processing in cancer

被引:2
作者
Biswas, Jeetayu [1 ,2 ]
Boussi, Leora [2 ]
Stein, Eytan [2 ]
Abdel-Wahab, Omar [1 ,2 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, New York, NY 10065 USA
[2] Mem Sloan Kettering Canc Ctr, Leukemia Serv, New York, NY 10065 USA
基金
美国国家卫生研究院;
关键词
SPLICING FACTOR SF3B1; 1ST-IN-HUMAN PHASE-I; MYELODYSPLASTIC SYNDROMES; DRIVER MUTATIONS; INTRON RETENTION; GENE-EXPRESSION; UVEAL MELANOMA; INHIBITOR; LEUKEMIA; MODULATION;
D O I
10.1084/jem.20230891
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
This review describes the current state of understanding of how RNA processing is dysregulated in cancer (including alterations in RNA splicing, capping, polyadenylation, and decay) and how this knowledge is being harnessed for therapeutic intent. Dysregulation of the flow of information from genomic DNA to RNA to protein occurs within all cancer types. In this review, we described the current state of understanding of how RNA processing is dysregulated in cancer with a focus on mutations in the RNA splicing factor machinery that are highly prevalent in hematologic malignancies. We discuss the downstream effects of these mutations highlighting both individual genes as well as common pathways that they perturb. We highlight examples of how alterations in RNA processing have been harnessed for therapeutic intent as well as to promote the selective toxicity of cancer cells.
引用
收藏
页数:14
相关论文
共 165 条
[1]   The GTEx Consortium atlas of genetic regulatory effects across human tissues [J].
Aguet, Francois ;
Barbeira, Alvaro N. ;
Bonazzola, Rodrigo ;
Brown, Andrew ;
Castel, Stephane E. ;
Jo, Brian ;
Kasela, Silva ;
Kim-Hellmuth, Sarah ;
Liang, Yanyu ;
Parsana, Princy ;
Flynn, Elise ;
Fresard, Laure ;
Gamazon, Eric R. ;
Hamel, Andrew R. ;
He, Yuan ;
Hormozdiari, Farhad ;
Mohammadi, Pejman ;
Munoz-Aguirre, Manuel ;
Ardlie, Kristin G. ;
Battle, Alexis ;
Bonazzola, Rodrigo ;
Brown, Christopher D. ;
Cox, Nancy ;
Dermitzakis, Emmanouil T. ;
Engelhardt, Barbara E. ;
Garrido-Martin, Diego ;
Gay, Nicole R. ;
Getz, Gad ;
Guigo, Roderic ;
Hamel, Andrew R. ;
Handsaker, Robert E. ;
He, Yuan ;
Hoffman, Paul J. ;
Hormozdiari, Farhad ;
Im, Hae Kyung ;
Jo, Brian ;
Kasela, Silva ;
Kashin, Seva ;
Kim-Hellmuth, Sarah ;
Kwong, Alan ;
Lappalainen, Tuuli ;
Li, Xiao ;
Liang, Yanyu ;
MacArthur, Daniel G. ;
Mohammadi, Pejman ;
Montgomery, Stephen B. ;
Munoz-Aguirre, Manuel ;
Rouhana, John M. ;
Hormozdiari, Farhad ;
Im, Hae Kyung .
SCIENCE, 2020, 369 (6509) :1318-1330
[2]   Genetic effects on gene expression across human tissues [J].
Aguet, Francois ;
Brown, Andrew A. ;
Castel, Stephane E. ;
Davis, Joe R. ;
He, Yuan ;
Jo, Brian ;
Mohammadi, Pejman ;
Park, Yoson ;
Parsana, Princy ;
Segre, Ayellet V. ;
Strober, Benjamin J. ;
Zappala, Zachary ;
Cummings, Beryl B. ;
Gelfand, Ellen T. ;
Hadley, Kane ;
Huang, Katherine H. ;
Lek, Monkol ;
Li, Xiao ;
Nedzel, Jared L. ;
Nguyen, Duyen Y. ;
Noble, Michael S. ;
Sullivan, Timothy J. ;
Tukiainen, Taru ;
MacArthur, Daniel G. ;
Getz, Gad ;
Management, Nih Program ;
Addington, Anjene ;
Guan, Ping ;
Koester, Susan ;
Little, A. Roger ;
Lockhart, Nicole C. ;
Moore, Helen M. ;
Rao, Abhi ;
Struewing, Jeffery P. ;
Volpi, Simona ;
Collection, Biospecimen ;
Brigham, Lori E. ;
Hasz, Richard ;
Hunter, Marcus ;
Johns, Christopher ;
Johnson, Mark ;
Kopen, Gene ;
Leinweber, William F. ;
Lonsdale, John T. ;
McDonald, Alisa ;
Mestichelli, Bernadette ;
Myer, Kevin ;
Roe, Bryan ;
Salvatore, Michael ;
Shad, Saboor .
NATURE, 2017, 550 (7675) :204-+
[3]   Ribosome biogenesis is a downstream effector of the oncogenic U2AF1-S34F mutation [J].
Akef, Abdalla ;
McGraw, Kathy ;
Cappell, Steven D. ;
Larson, Daniel R. .
PLOS BIOLOGY, 2020, 18 (11)
[4]   Phase 1/2 Multicenter, Open-Label Study of CTX-712 in Patients with Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes [J].
Al-Kali, Aref ;
Saliba, Antoine ;
Yi, Cecilia Y. Arana ;
Foran, James M. ;
Tanoue, Yasushi ;
Yamamoto, Maki ;
Gullbo, Joachim ;
Garcia-Manero, Guillermo .
BLOOD, 2023, 142
[5]   CPSF3 inhibition blocks pancreatic cancer cell proliferation through disruption of core histone mRNA processing [J].
Alahmari, Abdulrahman A. ;
Chaubey, Aditi H. ;
Jonnakuti, Venkata S. ;
Tisdale, Arwen A. ;
Schwarz, Carla D. ;
Cornwell, Abigail C. ;
Maraszek, Kathryn E. ;
Paterson, Emily J. ;
Kim, Minsuh ;
Venkat, Swati ;
Gomez, Eduardo Cortes ;
Wang, Jianmin ;
Gurova, Katerina V. ;
Yalamanchili, Hari Krishna ;
Feigin, Michael E. .
RNA, 2024, 30 (03) :281-297
[6]   Cancer-associated SF3B1 mutations affect alternative splicing by promoting alternative branchpoint usage [J].
Alsafadi, Samar ;
Houy, Alexandre ;
Battistella, Aude ;
Popova, Tatiana ;
Wassef, Michel ;
Henry, Emilie ;
Tirode, Franck ;
Constantinou, Angelos ;
Piperno-Neumann, Sophie ;
Roman-Roman, Sergio ;
Dutertre, Martin ;
Stern, Marc-Henri .
NATURE COMMUNICATIONS, 2016, 7
[7]  
Alvarado Y, 2007, J CLIN ONCOL, V25
[8]   KRAS4A directly regulates hexokinase 1 [J].
Amendola, Caroline R. ;
Mahaffey, James P. ;
Parker, Seth J. ;
Ahearn, Ian M. ;
Chen, Wei-Ching ;
Zhou, Mo ;
Court, Helen ;
Shi, Jie ;
Mendoza, Sebastian L. ;
Morten, Michael J. ;
Rothenberg, Eli ;
Gottlieb, Eyal ;
Wadghiri, Youssef Z. ;
Possemato, Richard ;
Hubbard, Stevan R. ;
Balmain, Allan ;
Kimmelman, Alec C. ;
Philips, Mark R. .
NATURE, 2019, 576 (7787) :482-+
[9]  
Ang Z, 2023, BLOOD, V142, P1724, DOI [10.1182/blood.2023020400, 10.1101/2023.02.19.529123]
[10]   Decoding Transcriptome Dynamics of Genome-Encoded Polyadenylation and Autoregulation with Small-Molecule Modulators of Alternative Polyadenylation [J].
Araki, Shinsuke ;
Nakayama, Yusuke ;
Sano, Osamu ;
Nakao, Shoichi ;
Shimizu-Ogasawara, Mari ;
Toyoshiba, Hiroyoshi ;
Nakanishi, Atsushi ;
Aparicio, Samuel .
CELL CHEMICAL BIOLOGY, 2018, 25 (12) :1470-+